Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Clinical Data

Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment

 April 2, 2026

BioSpace

COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.

Clinical DataInfectious DiseaseRead full story

Post navigation

AZ claims another win for Imfinzi in frontline liver cancer →
← Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com